Downregulation of Bax mRNA expression and protein stability by the E6 protein of human papillomavirus 16

被引:32
作者
Magal, SS
Jackman, A
Ish-Shalom, S
Botzer, LE
Gonen, P
Schlegel, R
Sherman, L [1 ]
机构
[1] Tel Aviv Univ, Sackler Sch Med, Dept Human Microbiol, IL-69978 Tel Aviv, Israel
[2] Georgetown Univ, Sch Med, Dept Pathol, Washington, DC USA
关键词
D O I
10.1099/vir.0.80453-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Previous studies have shown that human papillomavirus (HPV) 16 E6 inhibits apoptosis induced during terminal differentiation of primary human keratinocytes (PHKs) triggered by serum and calcium. E6 inhibition of apoptosis was accompanied with prolonged expression of Bcl-2 and reduced elevation of Bax levels. In the present study, the effect of E6 on Bax mRNA expression and protein stability was investigated. These studies indicate that stable E6 expression in differentiating keratinocytes reduced the steady-state levels of Bax mRNA and shortened the half-life of Bax protein. These results were confirmed in transiently transfected 293T cells where E6 degraded Bax in a dose-dependent manner. Bax degradation was also exhibited in Saos-2 cells that lack p53, indicating its p53 independence. E6 did not form complexes with Bax and did not induce Bax degradation in vitro under experimental conditions where p53 was degraded. Finally, E6 aa 120-132 were shown to be necessary for Bax destabilization and, more importantly, for abrogating the ability of Bax to induce cellular apoptosis, highlighting the functional consequences of the E6-induced alterations in Bax expression.
引用
收藏
页码:611 / 621
页数:11
相关论文
共 74 条
[1]   HPV16 E6 oncoprotein inhibits apoptosis induced during serum-calcium differentiation of foreskin human keratinocytes [J].
Alfandari, J ;
Magal, SS ;
Jackman, A ;
Schlegel, R ;
Gonen, P ;
Sherman, L .
VIROLOGY, 1999, 257 (02) :383-396
[2]   EXPRESSION OF THE BCL-2 GENE FAMILY IN NORMAL AND MALIGNANT BREAST-TISSUE - LOW BAX-ALPHA EXPRESSION IN TUMOR-CELLS CORRELATES WITH RESISTANCE TOWARDS APOPTOSIS [J].
BARGOU, RC ;
DANIEL, PT ;
MAPARA, MY ;
BOMMERT, K ;
WAGENER, C ;
KALLINICH, B ;
ROYER, HD ;
DORKEN, B .
INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (06) :854-859
[3]  
BUDTZ PE, 1994, APOPTOSIS, V2, P165
[4]   Human papillomavirus and cervical cancer [J].
Burd, EM .
CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (01) :1-+
[5]   GREEN FLUORESCENT PROTEIN AS A MARKER FOR GENE-EXPRESSION [J].
CHALFIE, M ;
TU, Y ;
EUSKIRCHEN, G ;
WARD, WW ;
PRASHER, DC .
SCIENCE, 1994, 263 (5148) :802-805
[6]  
Chang YC, 1998, CELL GROWTH DIFFER, V9, P79
[7]   INTERACTION OF PAPILLOMAVIRUS E6 ONCOPROTEINS WITH A PUTATIVE CALCIUM-BINDING PROTEIN [J].
CHEN, JJ ;
REID, CE ;
BAND, V ;
ANDROPHY, EJ .
SCIENCE, 1995, 269 (5223) :529-531
[8]   Gps2 a protein partner for human papillomavirus E6 proteins [J].
Degenhardt, YY ;
Silverstein, SJ .
JOURNAL OF VIROLOGY, 2001, 75 (01) :151-160
[9]  
Delehedde M, 1999, CANCER, V85, P1514, DOI 10.1002/(SICI)1097-0142(19990401)85:7<1514::AID-CNCR12>3.0.CO
[10]  
2-Q